1-1 of 1
Pauline Schaepelynck-Belicar, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)

Guillaume Charpentier, MD, Pierre-Yves Benhamou, MD, Dured Dardari, MD, Annie Clergeot, MD, Sylvia Franc, MD, Pauline Schaepelynck-Belicar, MD, Bogdan Catargi, MD, Vincent Melki, MD, Lucy Chaillous, MD, Anne Farret, MD, Jean-Luc Bosson, MD, Alfred Penfornis, MD, on behalf of the TeleDiab Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(3):533–539
https://doi.org/10.2337/dc10-1259
Published: 17 February 2011
View article titled, The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA<sub>1c</sub> in Poorly Controlled Type 1 Diabetic Patients: <subtitle>A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)</subtitle>
Open the PDF for The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA<sub>1c</sub> in Poorly Controlled Type 1 Diabetic Patients: <subtitle>A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)</subtitle> in another window
Includes: Supplementary data